As of 2025-09-18, the EV/EBITDA ratio of Maravai LifeSciences Holdings Inc (MRVI) is -29.17. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRVI's latest enterprise value is 773.06 mil USD. MRVI's TTM EBITDA according to its financial statements is -26.51 mil USD. Dividing these 2 quantities gives us the above MRVI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.1x - 13.6x | 12.6x |
| Forward P/E multiples | 14.6x - 22.6x | 18.4x |
| Fair Price | (1.74) - (1.63) | (1.83) |
| Upside | -161.8% - -158.1% | -165.2% |
| Date | EV/EBITDA |
| 2025-09-17 | -29.17 |
| 2025-09-16 | -29.94 |
| 2025-09-15 | -28.30 |
| 2025-09-12 | -27.82 |
| 2025-09-11 | -28.97 |
| 2025-09-10 | -27.14 |
| 2025-09-09 | -27.72 |
| 2025-09-08 | -25.60 |
| 2025-09-05 | -26.28 |
| 2025-09-04 | -24.83 |
| 2025-09-03 | -24.83 |
| 2025-09-02 | -24.93 |
| 2025-08-29 | -25.41 |
| 2025-08-28 | -25.02 |
| 2025-08-27 | -24.54 |
| 2025-08-26 | -25.41 |
| 2025-08-25 | -25.22 |
| 2025-08-22 | -25.70 |
| 2025-08-21 | -25.12 |
| 2025-08-20 | -25.79 |
| 2025-08-19 | -26.28 |
| 2025-08-18 | -26.85 |
| 2025-08-15 | -27.24 |
| 2025-08-14 | -27.14 |
| 2025-08-13 | -28.59 |
| 2025-08-12 | -28.01 |
| 2025-08-11 | -21.94 |
| 2025-08-08 | -23.29 |
| 2025-08-07 | -21.60 |
| 2025-08-06 | -21.70 |
| 2025-08-05 | -24.64 |
| 2025-08-04 | -23.96 |
| 2025-08-01 | -23.48 |
| 2025-07-31 | -24.64 |
| 2025-07-30 | -25.31 |
| 2025-07-29 | -25.99 |
| 2025-07-28 | -27.62 |
| 2025-07-25 | -28.01 |
| 2025-07-24 | -28.20 |
| 2025-07-23 | -27.33 |
| 2025-07-22 | -26.47 |
| 2025-07-21 | -25.02 |
| 2025-07-18 | -25.50 |
| 2025-07-17 | -26.28 |
| 2025-07-16 | -26.37 |
| 2025-07-15 | -27.05 |
| 2025-07-14 | -27.82 |
| 2025-07-11 | -28.39 |
| 2025-07-10 | -29.94 |
| 2025-07-09 | -28.68 |